|
Insider Trading: GTC BIOTHERAPEUTICS INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of GTC BIOTHERAPEUTICS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of GTC BIOTHERAPEUTICS INC since year 2005. Table 2 shows the detailed insider transactions of GTC BIOTHERAPEUTICS INC since 2005.
The reporting company's ticker symbol is GTCB.
The reporting company's CIK number is 904973.
The total value of stock buying since 2005 is $12,623,291.
The total value of stock sales is $51,018.
The total value of stock exercises is $0.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at GTC BIOTHERAPEUTICS INC (GTCB) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at GTC BIOTHERAPEUTICS INC (GTCB) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for GTC BIOTHERAPEUTICS INC (GTCB).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-03 | 100,400 | 48,192 | 39,930 | 22,699 | 0 | 0 |
| 2008-02 | 4,036,808 | 3,512,022 | 0 | 0 | 0 | 0 |
| 2007-12 | 44,565 | 39,431 | 0 | 0 | 0 | 0 |
| 2007-08 | 14,200 | 14,554 | 0 | 0 | 0 | 0 |
| 2007-03 | 24,000 | 24,000 | 0 | 0 | 0 | 0 |
| 2007-01 | 7,260,000 | 8,929,800 | 0 | 0 | 0 | 0 |
| 2006-12 | 0 | 0 | 7,500 | 8,220 | 0 | 0 |
| 2006-11 | 14,300 | 15,158 | 0 | 0 | 0 | 0 |
| 2006-09 | 3,421 | 4,242 | 0 | 0 | 0 | 0 |
| 2006-03 | 0 | 0 | 20,000 | 20,099 | 0 | 0 |
| 2005-11 | 3,000 | 4,824 | 0 | 0 | 0 | 0 |
| 2005-06 | 2,000 | 2,680 | 0 | 0 | 0 | 0 |
| 2005-05 | 9,000 | 10,125 | 0 | 0 | 0 | 0 |
| 2005-03 | 10,300 | 18,263 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for GTC BIOTHERAPEUTICS INC (GTCB)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-03-14 | Cox Geoffrey F (President, CEO and Chairman) | Purchase | 100,400 | .48 | 48,192 |
| 2008-03-12 | Liposky Gregory F (Senior VP, Operations) | Sale | 22,930 | .57 | 13,001 |
| 2008-03-12 | Woloshen Daniel S (Senior VP and General Counsel) | Sale | 17,000 | .57 | 9,698 |
| 2008-02-12 | Bechon Christian | Purchase | 2,018,404 | .87 | 1,756,011 |
| 2008-02-12 | Lfb Biotechnologies S.a.s.u. | Purchase | 2,018,404 | .87 | 1,756,011 |
| 2007-12-17 | Gray Mary Ann (Director) | Purchase | 10,000 | .88 | 8,800 |
| 2007-12-17 | Woloshen Daniel S (Senior VP and General Counsel) | Purchase | 1,200 | .89 | 1,068 |
| 2007-12-14 | Green John B (Senior VP and CFO) | Purchase | 1,500 | .89 | 1,334 |
| 2007-12-14 | Liposky Gregory F (Senior VP, Operations) | Purchase | 1,100 | .87 | 957 |
| 2007-12-14 | Meade Harry (SVP, Transgenic Research) | Purchase | 10,000 | .90 | 9,000 |
| 2007-12-14 | Geraghty James A (Director) | Purchase | 10,000 | .87 | 8,693 |
| 2007-12-13 | Cox Geoffrey F (President, CEO and Chairman) | Purchase | 10,765 | .89 | 9,579 |
| 2007-08-13 | Cox Geoffrey F (President, CEO and Chairman) | Purchase | 14,200 | 1.02 | 14,554 |
| 2007-03-14 | Cox Geoffrey F (President, CEO and Chairman) | Purchase | 24,000 | 1.00 | 24,000 |
| 2007-01-03 | Bechon Christian | Purchase | 3,630,000 | 1.23 | 4,464,900 |
| 2007-01-03 | Lfb Biotechnologies S.a.s.u. | Purchase | 3,630,000 | 1.23 | 4,464,900 |
| 2006-12-22 | Woloshen Daniel S (Senior VP and General Counsel) | Sale | 7,500 | 1.10 | 8,220 |
| 2006-11-06 | Cox Geoffrey F (President, CEO and Chairman) | Purchase | 14,300 | 1.06 | 15,158 |
| 2006-09-29 | Geraghty James A (Director) | Purchase | 2,621 | 1.24 | 3,250 |
| 2006-09-29 | Tuck Alan W (Director) | Purchase | 800 | 1.24 | 992 |
| 2006-03-17 | Liposky Gregory F (Senior VP, Operations) | Sale | 20,000 | 1.00 | 20,099 |
| 2005-11-11 | Geraghty James A (Director) | Purchase | 3,000 | 1.61 | 4,824 |
| 2005-06-01 | Tuck Alan W (Director) | Purchase | 2,000 | 1.34 | 2,680 |
| 2005-05-16 | Green John B (SVP and CFO) | Purchase | 1,000 | 1.39 | 1,390 |
| 2005-05-16 | Geraghty James A (Director) | Purchase | 3,000 | 1.32 | 3,960 |
| 2005-05-04 | Cox Geoffrey F (President, CEO and C) | Purchase | 5,000 | .96 | 4,775 |
| 2005-03-15 | Cox Geoffrey F (President, CEO and C) | Purchase | 5,300 | 1.80 | 9,513 |
| 2005-03-14 | Geraghty James A (Director) | Purchase | 5,000 | 1.75 | 8,750 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of GTC BIOTHERAPEUTICS INC (symbol GTCB,
CIK number 904973) see
the Securities and Exchange Commission (SEC) website.
|
|
